Outlook ES pump is intended for use with B. Braun Medical Inc. Horizon Pump IV Sets. Used to regu...
FDA Device Recall #Z-2163-2013 — Class II — October 24, 2012
Recall Summary
| Recall Number | Z-2163-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 24, 2012 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | B Braun Medical, Inc. |
| Location | Carrollton, TX |
| Product Type | Devices |
| Quantity | 28,427 |
Product Description
Outlook ES pump is intended for use with B. Braun Medical Inc. Horizon Pump IV Sets. Used to regulate the flow of primary and secondary fluids when positive pressure is required. The infusion system is capable of delivering fluid from a negative head height (when the IV fluid container is lower than the pump), and provides clinically accepted volumetric accuracy for all standard IV fluids, including blood, lipid, and Total Parenteral Nutrition (TPN). Model number: 621-100ES, 621-200ES, 621-300ES, and 621-400ES. To deliver a broad range of drugs with use with the B. Braun Medical Inc. Horizon Pump IV Sets.
Reason for Recall
B. Braun Medical Inc. has become aware of an issue with the Outlook ES Safety Infusion System. The key panel may fail to function as intended if the underlying circuitry fails due to intermittent contact. This issue applies specifically to the HOLD button. If this occurs, the Door Processor (DP) will not receive the desired input from the user. This issue can be observed in pumps with key panels
Distribution Pattern
Nationwide Distribution.
Lot / Code Information
Multiple serial numbers affected. Model number: 621-100ES, 621-200ES, 621-300ES, and 621-400ES.
Other Recalls from B Braun Medical, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0718-2021 | Class II | APEX Compounding System Control Panel Module, R... | Nov 23, 2020 |
| Z-0717-2021 | Class II | APEX Compounding System Control Panel Module, R... | Nov 23, 2020 |
| Z-0719-2021 | Class II | APEX Compounding System Control Panel Module, R... | Nov 23, 2020 |
| Z-2175-2013 | Class II | Outlook ES pump is intended for use with B. Bra... | Dec 5, 2012 |
| Z-2188-2013 | Class I | Outlook ES pump is intended for use with B. Bra... | Nov 14, 2012 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.